Advanced Health Limited provides earnings guidance for the period ended 31 December 2022. The Company expects a loss and headline loss per share from continuing operations of 4.18 cents, 27% higher than the loss per share from continuing operations of 3.29 cents in the comparative period (prior year restated to exclude discontinued operations).